Abstract
Preservatives are an important component of ophthalmic preparations, providing antimicrobial activity in the bottle and preventing decomposition of active drug. Often underrecognized, however, are the significant cytotoxic effects of preservatives associated with long-term therapy and especially use of multiple preserved drugs. The most common preservatives in ophthalmic preparations for glaucoma and surface eye disease—benzalkonium chloride (BAK), chlorobutanol, sodium perborate, and stabilized oxychloro complex (SOC)—were reviewed. Compared with other preservatives, SOC caused the least amount of damage to rabbit corneal epithelial cells. BAK has demonstrated cytotoxic effects in cell culture, as well as in animal and human studies. Physicians should consider treatment with new-generation preparations containing low-risk preservatives such as SOC, especially in patients receiving multiple ophthalmic medications.
Similar content being viewed by others
References
Schein OD, Hibberd PL, Starck T, Baker AS, Kenyon KR. Microbial contamination of in-use ocular medications.Arch Ophthalmol. 1992;110:82–85.
Tripathi BJ, Tripathi RC, Kolli SP. Cytotoxicity of ophthalmic preservatives on human corneal epithelium.Lens Eye Toxicol Res. 1992;9:361–375.
Pisella PJ, Fillacier K, Elena PP, Debbasch C, Baudouin C. Comparison of the effects of pre served and unpreserved formulations of timolol on the ocular surface of albino rabbits.Ophthalmic Res. 2000;32:3–8.
Gasset AR, Ishii Y, Kaufman HE, Miller T. Cytotoxicity of ophthalmic preservatives.Am J Ophthalmol. 1974;78:98–105.
Berdy GJ, Abelson MB, Smith LM, George MA. Preservative-free artificial tear preparations. Assessment of corneal epithelial toxic effects.Arch Ophthalmol. 1992;110:528–532.
Debbasch C, Rat P, Warnet J-M, De Saint Jean M, Baudouin C, Pisella P-J. Evaluation of the toxici ty of benzalkonium chloride on the ocular surface.J Toxicol Cutan Ocul Toxicol. 2000;19:105–115.
Baudouin C. Side effects of antiglaucomatous drugs on the ocular surface.Curr Opin Ophthalmol. 1996;7:80–86.
Baudouin C. Mechanisms of failure in glaucoma filtering surgery: a consequence of antiglauco matous drugs?Int J Clin Pharmacol Res. 1996;16:29–41.
Broadway DC, Grierson I, O’Brien C, Hitchings RA. Adverse effects of topical antiglaucoma medication, I: the conjunctival cell profile.Arch Ophthalmol. 1994;112:1437–1445.
Sherwood MB, Grierson I, Millar L, Hitchings RA. Long-term morphologic effects of antiglauco ma drugs on the conjunctiva and Tenon’s capsule in glaucomatous patients.Ophthalmology. 1989;96:327–335.
Wilson WS, Duncan AJ, Jay JL. Effect of benzalkonium chloride on the stability of the precorneal tear film in rabbit and man.Br J Ophthalmol. 1975;59:667–669.
Spickett C.Studies of Cellular Responses to Purite and Other Preservatives. Strathclyde, UK: University of Strathclyde; 2001.
Block SS.Disinfection, Sterilization, and Preservation. Malvern, Pa: Lea & Febiger; 1991.
Kreiner C. Biochemical aspects of ophthalmic preservatives.Contacto. 1979;Nov:10-14.
Grant WM, Schuman JS.Toxicology of the Eye. Springfield, Ill: Charles C Thomas; 1990.
Grant R, Ajello M, Vlass E. Salt water or high tech? A look at two new rinsing solutions for contact lenses.Optician. 1996;212:38–41.
Masschelein WJ, Rice RG.Chlorine Dioxide. Chemistry and Environmental Impact of Oxychlorine Compounds. Ann Arbor, Mich: Ann Arbor Science Publishers; 1979.
Rozen S, Abelson M, Giovanoni A, Welch D. Assessment of the comfort and tolerance of 0.5% carboxymethylcellulose preserved with Purite (Refresh Tears) in dry eye sufferers.Invest Ophthalmol Vis Sci. 1998;39(4):S451.
Vaughan JS, Porter DA. A new in vitro method for assessing the potential toxicity of soft contact lens care solutions.CLAO J. 1993;19:54–57.
Paugh JR, Brennan NA, Efron N. Ocular response to hydrogen peroxide.Am J Optom Physiol Opt. 1988;65:91–98.
Seiler JP. The mutagenic activity of sodium perborate.Mutat Res. 1989;224:219–227.
Campagna P, Macri A, Rolando M, Calabria G. Chronic topical eye preservative-free beta-blocker therapy effect on the ocular surface in glaucomatous patients.Acta Ophthalmol Scand Suppl. 1997;224:53.
De Saint Jean M, Debbasch C, Brignole F, Rat P, Warnet JM, Baudouin C. Toxicity of preserved and unpreserved antiglaucoma topical drugs in an in vitro model of conjunctival cells.Curr Eye Res. 2000;20:85–94.
Yalvac IS, Gedikoglu G, Karagoz Y, et al. Effects of antiglaucoma drugs on ocular surface.Acta Ophthalmol Scand. 1995;73:246–248.
Turacli E, Budak K, Kaur A, Mizrak B, Ekinci C. The effects of long-term topical glaucoma medication on conjunctival impression cytology.Int Ophthalmol. 1997;21:27–33.
Arici MK, Arici DS, Topalkara A, Guler C. Adverse effects of topical antiglaucoma drugs on the ocular surface.Clin Exp Ophthalmol. 2000;28:113–117.
Gobbels M, Spitznas M. Corneal epithelial permeability of dry eyes before and after treatment with artificial tears.Ophthalmology. 1992;99:873–878.
Holly FJ. Surface chemical evaluation of artificial tears and their ingredients, II: interaction with a superficial lipid layer.Contact Lens. 1978;4:52–65.
Baudouin C, de Lunardo C. Short-term comparative study of topical 2% carteolol with and without benzalkonium chloride in healthy volunteers.Br J Ophthalmol. 1998;82:39–42.
Tomlinson A, Trees GR. Effect of preservatives in artificial tear solutions on tear film evaporation.Ophthalmic Physiol Opt. 1991;11:48–52.
Gupta M, Majumdar DK. Effect of concentration, pH, and preservative on in vitro transcorneal permeation of ibuprofen and flurbiprofen from non-buffered aqueous drops.Indian J Exp Biol. 1997;35:844–849.
Fassihi AR, Naidoo NT. Irritation associated with tear-replacement ophthalmic drops. A pharmaceutical and subjective investigation.S Afr Med J. 1989;75:233–235.
Tripathi BJ, Tripathi RC. Cytotoxic effects of benzalkonium chloride and chlorobutanol on human corneal epithelial cells in vitro.Lens Eye Toxicol Res. 1989;6:395–403.
Collin HB. Ultrastructural changes to corneal stromal cells due to ophthalmic preservatives.Acta Ophthalmol (Copenh). 1986;64:72–78.
Burstein NL, Klyce SD. Electrophysiologic and morphologic effects of ophthalmic preparations on rabbit cornea epithelium.Invest Ophthalmol Vis Sci. 1977;16:899–911.
Burstein N. Corneal cytotoxicity of topically applied drugs, vehicles, and preservatives.Surv Ophthalmol. 1980;25:15.
Doughty MJ. Twice-daily use of a chlorobutanol-preserved artificial tear on rabbit corneal epithelium assessed by scanning electron microscopy.Ophthalmic Physiol Opt. 1992;12:457–466.
Lazarus HM, Imperia PS, Botti RE, Mack RJ, Lass JH. An in vitro method which assesses corneal epithelial toxicity due to antineoplastic, preservative and antimicrobial agents.Lens Eye Toxicol Res. 1989;6:59–85.
Way WA, Matsumoto S, Apel LJ, Wiese A, Tarlo K, Vehige J. Purite™ as a non-disruptive preservative for lubricating eye drop solutions in comparison to alternative preservatives.Invest Ophthalmol Vis Sci. 2001;42:S39.
Walters TR, Batoosingh AL. 12-Month evaluation of brimonidine-Purite compared with brimonidine in patients with glaucoma or ocular hypertension.Invest Ophthalmol Vis Sci. 2001; 42:S558.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Noecker, R. Effects of common ophthalmic preservatives on ocular health. Adv Therapy 18, 205–215 (2001). https://doi.org/10.1007/BF02853166
Issue Date:
DOI: https://doi.org/10.1007/BF02853166